COVIDIEN TO INVEST IN DCU's BIOMEDICAL DIAGNOSTIC INSTITUTE
Medical devices group, Covidien, has announced plans to invest in an innovative R&D project with the Biomedical Diagnostic Institute. The project is included in a total investment of up to €25 million in six separate research and development projects in Ireland in association with IDA Ireland.
The company employs 1,500 people at six plants across the State, and the R&D projects will be focused on the area of respiratory technology.
Covidien chief executive José Almeida said the decision to invest in R&D here was down to Ireland's record of fostering innovation.
"These advanced research and development projects represent a significant future pipeline of innovative products for Covidien. They also may produce important data to further patient health and safety."
Institute Director, Professor Michael Berndt, commented, "We are delighted that Covidien has recognised the expertise of the BDI as a centre of excellence in point-of-care diagnostic development and we look forward to working with them."
In this project, the BDI will collaborate with colleagues from the National Center for Sensor Research at DCU, the Royal College of Surgeons of Ireland and University College Dublin.